Stock Track | Zylox-Tonbridge Medical Soars 5.27% Intraday on Strong 2025 Earnings and Acquisition News

Stock Track03-18

Shares of Zylox-Tonbridge Medical Technology (ZYLOXTB) soared 5.27% during intraday trading on Wednesday.

The significant price movement follows the company's release of its 2025 financial results, which showed profit attributable to equity holders more than doubled to 244.4 million yuan from 100.3 million yuan a year earlier. Revenue also saw strong growth, increasing by 35% to 1.06 billion yuan.

Investor sentiment was further buoyed by a separate announcement that the company exercised an option to acquire an additional 11% stake in German medical technology firm Optimed Holding, a strategic move to expand its business portfolio. The board has also proposed a final dividend, pending shareholder approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1107602493?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-18 14:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107602493","market":"sg","top_or_hot":-1,"title":"Stock Track | Zylox-Tonbridge Medical Soars 5.27% Intraday on Strong 2025 Earnings and Acquisition News","media":"Stock Track","content":"<p>Shares of Zylox-Tonbridge Medical Technology (ZYLOXTB) soared 5.27% during intraday trading on Wednesday.</p><p>The significant price movement follows the company's release of its 2025 financial results, which showed profit attributable to equity holders more than doubled to 244.4 million yuan from 100.3 million yuan a year earlier. Revenue also saw strong growth, increasing by 35% to 1.06 billion yuan.</p><p>Investor sentiment was further buoyed by a separate announcement that the company exercised an option to acquire an additional 11% stake in German medical technology firm Optimed Holding, a strategic move to expand its business portfolio. The board has also proposed a final dividend, pending shareholder approval.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Zylox-Tonbridge Medical Soars 5.27% Intraday on Strong 2025 Earnings and Acquisition News</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Zylox-Tonbridge Medical Soars 5.27% Intraday on Strong 2025 Earnings and Acquisition News\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-18 14:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Zylox-Tonbridge Medical Technology (ZYLOXTB) soared 5.27% during intraday trading on Wednesday.</p><p>The significant price movement follows the company's release of its 2025 financial results, which showed profit attributable to equity holders more than doubled to 244.4 million yuan from 100.3 million yuan a year earlier. Revenue also saw strong growth, increasing by 35% to 1.06 billion yuan.</p><p>Investor sentiment was further buoyed by a separate announcement that the company exercised an option to acquire an additional 11% stake in German medical technology firm Optimed Holding, a strategic move to expand its business portfolio. The board has also proposed a final dividend, pending shareholder approval.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02190","symbol_name":"归创通桥","start_time":0,"source_url":"","article_id":"1107602493","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107602493","pubTimestamp":1773814768,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Zylox-Tonbridge Medical Technology (ZYLOXTB) soared 5.27% during intraday trading on Wednesday.The significant price movement follows the company's release of its 2025 financial results,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02190":"归创通桥"},"translate_title":"个股追踪|归乐通桥医疗盘中大涨5.27%，因2025年财报及收购消息强劲","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02190":1},"content_text":"Shares of Zylox-Tonbridge Medical Technology (ZYLOXTB) soared 5.27% during intraday trading on Wednesday.The significant price movement follows the company's release of its 2025 financial results, which showed profit attributable to equity holders more than doubled to 244.4 million yuan from 100.3 million yuan a year earlier. Revenue also saw strong growth, increasing by 35% to 1.06 billion yuan.Investor sentiment was further buoyed by a separate announcement that the company exercised an option to acquire an additional 11% stake in German medical technology firm Optimed Holding, a strategic move to expand its business portfolio. The board has also proposed a final dividend, pending shareholder approval.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1107602493","isCrawlerRequest":true}